California AB260 ensures access to abortion care and medication abortion.
California AB260 prohibits insurers from limiting coverage for mifepristone and other medication abortion drugs. It also prohibits health care service plans and insurers from penalizing providers for lawful abortion-related activities. The bill mandates coverage for mifepristone if certain conditions are met, even if the drug is not FDA-approved for abortion. It ensures incarcerated and detained individuals have access to abortion care. The bill also modifies telehealth regulations to allow for remote service delivery under certain conditions.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.